Orphan drug legislation: lessons for neg
β
Stefano Villa; Amelia Compagni; Michael R. Reich
π
Article
π
2009
π
John Wiley and Sons
π
English
β 109 KB
## Abstract In the last 20 years, orphan drug legislation (ODL) has been adopted in several countries around the world (USA, Japan, Australia, and the European Union) and has successfully promoted R&D investments to develop new pharmaceutical products for the treatment of rare diseases. Without the